Michael Davis takes a permanent leadership role at the FDA's Center for Drug Evaluation and Research following senior selections announced by the Department of Health & Human Services.
1 report, 1 independent
Updated Sep 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Michael Davis takes a permanent leadership role at the FDA's Center for Drug Evaluation and Research following senior selections announced by the Department of Health & Human Services.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Center for Drug Evaluation and Research
FDA research center
Nothing else this week.
-
Michael Davis
British writer
Nothing else this week.
Related events
- FDA, LabCorp, and Charles River Laboratories formed a collaboration to evaluate the potential for medicine abuse.
- FDA placed a clinical hold on the drug application submitted by Bright Minds Biosciences Inc.
- Vance Thompson Vision advocated for standard product approval during an FDA committee meeting chaired by Michael X. Repka.
- AMA urges FDA to maintain standards as federal government implements marijuana rescheduling order amid GAO findings of regulatory deficiencies.
- Steven Abrams commented on the FDA's nutrition update review, which is part of a Trump administration initiative.